Promis Diagnostics
Where Convenience Meets Quality
- Employees
- 11–50
- Business Model
- B2B
- Website
- promisdx.com
About
Promis Diagnostics is a biotech company focused on non-invasive early cancer detection using its proprietary LTE-qMSP technology platform. The company's EarlyTect product line detects bladder, colorectal, and lung cancer through urine or liquid biopsy samples by identifying methylated DNA biomarkers via PCR, enabling high sensitivity and specificity from minute sample quantities. Promis Diagnostics serves clinical laboratories, urologists, and healthcare systems, and its EarlyTect BCD product has been recognized in the 2025 AUA/SUFU Microhematuria Guideline as a validated urinary biomarker option.
Summary
Promis Diagnostics is a Biotech company.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/promis-diagnostics"><img src="https://indexed.vc/api/badge/company/promis-diagnostics" alt="Promis Diagnostics on Indexed.vc" width="260" height="76" /></a>